Dekalin VT, the active ingredient of this tablet, belongs to the family of anti-infective and antiseptic drugs. Dekalin VT is active against the bacteria which cause bacterial vaginosis. Dekalin VT is used for the treatment of bacterial vaginosis. It is inserted into the vagina for the treatment of the site of infection.
Adult : The recommended dose is 1 vaginal tablet daily for 6 days. Children and adolescents : There is insufficient experience of the use of Dequalinium chloride in children and adolescents under 18 years of age. Women above 55 years and elderly : There is insufficient experience of the use of Dequalinium chloride in women above 55 years. Use in Pregnancy & Lactation : Based on previous experience and since this vaginal tablet acts locally, no harmful effects on pregnancy and/or the unborn and breast fed infant are expected. This vaginal tablet should only be used during pregnancy and during breast-feeding if medically needed.
Like all medicines, this medicine can cause side effects, although not everybody gets them. Most of the side effects are mild and short lived. Sometimes the symptoms of vaginal infections (such as- Vaginal discharge, vaginal itching or vaginal burning, Vaginal yeast infection, thrush.) can get worse at the beginning of the treatment, before they start to get better. The treatment should be continued with the treatment, but if the complaints persist, please take advice from doctors. Some other side effects are- Vaginal bleeding, vaginal pain Inflammation of vagina Headache Nausea
Always consult a registered doctor before taking any medicine. This information is for general knowledge only.
Hypersensitivity to the active substance or to any of the excipients present in medication. Ulceration of the vaginal epithelium and the vaginal portion of the cervix. Those who have not yet had their first menstruation, and thus did not reach sexual maturity must not use This tablet.
Intravaginal use of soaps, spermicides and vaginal douches (vaginal washes) is not recommended during treatment with this vaginal tablet. Treatment should be stopped during the heavy bleeding period of menstruation and resume afterwards. As with all vaginal infections, unprotected sexual intercourse during treatment with this vaginal tablet is prohibited. To minimise exposure of the newborn to Dekalin VT, vaginal tablets should not be used within 12 hours before birth.